<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE335nnn/GSE335176/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Methylation profiling</omics_type><species>Homo sapiens</species><gds_type>Methylation profiling by genome tiling array</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE335176</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Genomic hallmarks of depot medroxyprogesterone acetate-associated meningiomas [methylation]</name><description>Integrated genomic characterization of meningiomas from 10 women with long-term exposure to depot medroxyprogesterone acetate (DMPA), a commonly used injectable progestin contraceptive. All tumors were newly diagnosed WHO grade 1 meningiomas. We profiled genome-wide DNA methylation (Illumina Infinium MethylationEPIC v2.0) and performed bulk RNA sequencing on all 10 tumors, and integrated these data with public reference meningioma cohorts (Baylor, GSE189521; Heidelberg, GSE109381) for methylation classifier assignment, consensus clustering, copy-number analysis, and differential methylation testing.</description><dates><publication>2026/06/12</publication></dates><accession>GSE335176</accession><cross_references><GSM>GSM9807651</GSM><GSM>GSM9807650</GSM><GSM>GSM9807653</GSM><GSM>GSM9807652</GSM><GSM>GSM9807655</GSM><GSM>GSM9807654</GSM><GSM>GSM9807657</GSM><GSM>GSM9807656</GSM><GSM>GSM9807658</GSM><GSM>GSM9807649</GSM><GPL>33022</GPL><GSE>335176</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>